Pharmaceutical price controls in President Biden’s budget and the SMART Choices Act will devastate drug development.
Patients Pay the Ultimate Price for Price Controls
Price controls on pharmaceuticals distort the medical marketplace and will not lower drug prices.
The Inflation Reduction Act Is a Death Sentence for Patients
The IRA will be devastating to patients in need of future cures and treatments.
New Study Confirms 340B Program is Exploited
A new study, “340B and Health Equity: A Missed Opportunity in Medically Underserved Areas,” shows the program is misused.
Salvage the Good from the Healthcare Debacle
The healthcare reform juggernaut, arguably the most radical attempt to remake the economy and the nation’s healthcare infrastructure in history, was supposed to have flown through Congress before the August recess with nary a peep. Instead, as Americans have gotten wind of its alarming provisions and exorbitant costs, the plan appears to be fizzling fast in the summer heat.